431 results on '"Martelli, M. F."'
Search Results
2. The NOTCH1/CD39 axis: a Treg trip-switch for GvHD
3. P574: CPX-351 COMBINED WITH HEMATOPOIETIC CELL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY FOR HIGH-RISK ACUTE MYELOID LEUKEMIA
4. Megadose Stem Cell Transplantation
5. Next generation HLA-haploidentical HSCT
6. Haploidentical hematopoietic stem cell transplantation: state of art
7. Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT
8. A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia
9. In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML
10. Different genomic imbalances in low- and high-grade HCV-related lymphomas
11. Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML
12. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
13. Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation
14. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome
15. FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells
16. Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia
17. Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
18. Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML
19. Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy
20. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
21. CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients
22. Adoptive immunotherapy with Tregs and Tcons rebuilds post transplant immunity and is associated with low TRM in HLA-haploidentical transplantation: O143
23. Haploidentical stem cell transplantation for acute leukemia
24. 5-Azacytidine prevents transgene methylation in vivo
25. A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene
26. Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications
27. Adoptive immunotherapy after haploidentical stem cell transplantation with T-cells allodepleted by photodynamic purging
28. TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemia
29. A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera
30. Haplo-identical haematopoietic stem cell transplantation for secondary leukaemia
31. Impact of NK cell alloreactivity on mismatched haematopoietic transplantation: an update on donor selection criteria and on transplantation outcomes
32. Human stromal cells engineered with interleukin-7 enhance the survival of naive T-lymphocytes
33. Transferring donor immunity to pathogens across HLA barriers
34. Interferon alpha-2b in the long-term treatment of essential thrombocythemia
35. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation
36. Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas
37. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens
38. The Effect of Thymostimulin on the Immunologic Parameters of Patients with Untreated Hodgkin’s Disease
39. Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term α-IFN treatment
40. Next gebneration in HLA-haploidentical HSCT
41. STUDIO DELLA RICOSTITUZIONE IMMUNOLOGICAASPERGILLO-SPECIFICA IN TRAPIANTI DICELLULE STAMINALI EMOPOIETICHE T-REPLETI E T-DEPLETI. XL Congresso Nazionale Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Lecce 24-26 maggio 2015
42. TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemia [4]
43. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole
44. Immunoselection and clinical use of T regulatory cells in HLA haploidentical stem cell transplantation
45. CD34-POSITIVE HEMATOPOIETIC PROGENITOR CELLS ARE INVOLVED IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION
46. IN THE HUMAN GENOME, ONLY FEW GENES CAN BE A TARGET FOR DUPLICATION ENCODING A NUCLEAR LOCALIZATION SIGNAL
47. A one-mutation mathematical model can explain the age incidence of AML with mutated nucleophosmin (NPM1)
48. Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML
49. NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype
50. NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.